Patients with early-stage myelodysplastic syndromes show increased frequency of CD4?high?low Regulatory T Cells

Acta Haematologica

Volumn 128, Issue 3, 2012, Pages 178-182

  Fozza, Claudio ^a   Longu, Francesco ^a   Contini, Salvatore ^a   Galleu, Antonio ^a   Virdis, Patrizia ^a   Bonfigli, Silvana ^a   Murineddu, Marco ^b   Gabbas, Attilio ^b   Longinotti, Maurizio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b SAN FRANCESCO HOSPITAL   (Italy)

Author keywords

CD4?high?low; Flow cytometry; Myelodysplastic syndromes; Regulatory T cells

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR;

ADULT; AGED; ARTICLE; CD4+ CD24+ CD127+ REGULATORY T CELL; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY;

AGED; AGED, 80 AND OVER; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; T-LYMPHOCYTES, REGULATORY;

EID: 84864824602     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000339498     Document Type: Article

References (10)

1. Sakaguchi S, Miyara M, Costantino CM, Hafler DA: FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
2. Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, Longinotti M: Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Exp Hematol 2009; 37: 947-955.
3. Smith MA, Smith JG: The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leuk Res 1991; 15: 597-601.
4. Alfinito F, Sica M, Luciano L, Pepa RD, Palladino C, Ferrara I, Giani U, Ruggiero G, Terrazzano G: Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes. Br J Haematol 2010; 148: 90-98.
5. Kordasti SY, Ingram W, Hayden J, Darling D, Barber L, Afzali B, Lombardi G, Wlodarski MW, Maciejewski JP, Farzaneh F, Mufti GJ: CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 2007; 110: 847-850.
6. Kotsianidis I, Bouchliou I, Nakou E, Spanoudakis E, Margaritis D, Christophoridou AV, Anastasiades A, Tsigalou C, Bourikas G, Karadimitris A, Tsatalas C: Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia 2009; 23: 510-518.
7. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM: Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007; 319: 41-52.
8. Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-2302.
9. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M: Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007; 25: 3503-3510.
10. Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Bellucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J: Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005; 106: 2903-2911.